ArticleOncotarget2017

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E.

Lingxiao Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.